Tellgen Corporation, founded in 2003, produces advanced diagnostic products for cancer, autoimmune, cardiovascular, pathogen infections, and reproductive health with immunoassay, molecular, biochemistry, and LC-MS/MS. They use cutting-edge technology, and have 400 NMPA registration certificates, 168 CE IVDs, and 8 US FDA certified assays. They are dedicated to providing top-quality service and products, and are always researching new frontiers in R&D to improve human health.
CN: www.tellgen.com